產(chǎn)品概述
IL-3是一種多效性的細(xì)胞因子,可刺激細(xì)胞的增殖分化并刺激多功能造血干細(xì)胞和譜系定向祖細(xì)胞的存活。表達(dá)IL-3的細(xì)胞有幾種造血和非造血細(xì)胞包括激活后的人的T細(xì)胞,自然殺傷性細(xì)胞,肥大細(xì)胞,上皮細(xì)胞,基質(zhì)細(xì)胞,鼠角質(zhì)細(xì)胞,神經(jīng)元和星形膠質(zhì)細(xì)胞。人的IL-3的核苷酸序列是由133個(gè)氨基酸組成的多肽序列和19個(gè)氨基酸組成的信號(hào)序列。在氨基酸水平上,小鼠和人的氨基酸序列只有29%的同源性,雖然同源性比較低,但是在他們?cè)诠δ苤芯唧w種屬特異性。IL-3不僅對(duì)造血干細(xì)胞有影響,還可以刺激人的內(nèi)皮細(xì)胞和平滑肌細(xì)胞的增殖和運(yùn)動(dòng)。IL-3被證明可以作為神經(jīng)營(yíng)養(yǎng)因子促進(jìn)神經(jīng)元的存活和神經(jīng)突的生長(zhǎng)。
產(chǎn)品原理
本實(shí)驗(yàn)采用雙抗體夾心ELISA法??谷薎L-3單抗包被于酶標(biāo)板上,標(biāo)本和標(biāo)準(zhǔn)品中的IL-3會(huì)與單抗結(jié)合形成免疫復(fù)合物,游離的成分被洗去;加入生物素化的抗人IL-3抗體,生物素化抗人IL-3抗體與酶標(biāo)板上結(jié)合的標(biāo)準(zhǔn)品或樣本中的IL-3結(jié)合而形成免疫復(fù)合物,游離的成分被洗去;加入辣根過氧化物酶標(biāo)記的親合素,親合素與生物素特異性結(jié)合,游離的成分被洗去。加入顯色底物(顯色劑),若反應(yīng)孔中有IL-3,辣根過氧化物酶會(huì)使無色的顯色劑變藍(lán),加終止液變黃。在450nm處測(cè)OD值,IL-3濃度與OD450值之間呈正相關(guān),可通過繪制標(biāo)準(zhǔn)曲線求出標(biāo)本中IL-3濃度。
Zhang ZY et al. MitochondrialDNA-LL-37Complex Promotes Atherosclerosis by Escaping from AutophagicRecognition.Immunity, 2015. Read more (PubMed : 26680206)
Wang H et al. Loss ofYTHDF2-mediatedm6A-dependent mRNA clearance facilitates hematopoietic stem cellregeneration. CellResearch, 2018. Read more (PubMed : 30150673)
Zhang SY et al.Adipocyte-derivedLysophosphatidylcholine Activates Adipocyte and Adipose TissueMacrophage Nod-LikeReceptor Protein 3 Inflammasomes Mediating Homocysteine-InducedInsulinResistance.EBioMedicine, 2018. Read more (Pubmed : 29735414)
He W et al. Vitamin B5 ReducesBacterialGrowth via Regulating Innate Immunity and Adaptive Immunity in MiceInfectedwith Mycobacterium tuberculosis. Front Immunol, 2018. Read more (Pubmed :29535733)
Teng J et al. High-sensitiveimmunosensingof protein biomarker based on interfacial recognition-inducedhomogeneousexponential transcription.Anal Chim Acta, 2019. Read More (PubMed : 31047141)
He MC et al. Paricalcitolalleviateslipopolysaccharide-induced depressive-like behavior by suppressinghypothalamicmicroglia activation and neuroinflammation. Biochem Pharmacol,2019. Read More (Pubmed :30703351)
Su R et al. A NovelImmunosuppressor,(5R)-5-Hydroxytriptolide, Alleviates Movement Disorder andNeuroinflammation ina 6-OHDA Hemiparkinsonian Rat Model. Aging and Disease,2017. Read More (PubMed: 28203480)